David Rosen

David Rosen has extensive work experience in various leadership roles within the biomedical industry. David is currently the Chief Executive Officer at A3P Biomedical, a position they have held since June 2021. Before their current role, they served as the Director at Neoventor AB from August 2020 onwards. Prior to that, they were the Director at AirRevival Ltd. starting from September 2013.

From 2015 to 2019, David worked at Cantel Medical, where they held multiple positions. David was the President Continental Europe, Middle East & Asia-Pacific from June 2016 to April 2019. Before that, they served as the President Asia-Pacific & Emerging Markets from August 2015 to May 2016.

Before joining Cantel Medical, David worked at Getinge Infection Control AB from 2005 to 2015. During their tenure, they held various leadership roles, including President Asia-Pacific and Area General Manager for South Asia, Southeast Asia & Oceania.

David started their career at Cellectricon in 2003 as the Vice President of Marketing & Sales. Prior to that, they worked at Neoventa Medical, where they held positions such as Marketing & Sales Director and International Product Director.

Overall, David Rosen has a strong background in executive roles within the biomedical industry, with a focus on sales, marketing, and international operations.

David Rosen earned their Master of Science (M.Sc.) degree in Economics from the University of Gothenburg, where they studied from 1993 to 1997.